DLB

Dolby Laboratories
NYSEINDUSTRIALSSPECIALTY BUSINESS SERVICES

Key Statistics

Market Cap
$5.62B
P/E Ratio
25.51
EPS
$2.35
Beta
0.78
52W High
$69.11
52W Low
$47.98
50-Day MA
$60.70
200-Day MA
$59.36
Dividend Yield
2.37%
Profit Margin
16.70%
Forward P/E
12.61
PEG Ratio
2.08

About Dolby Laboratories

Dolby Laboratories, Inc. creates imaging and audio technologies that transform entertainment and communications in the theater, home, work, and mobile devices. The company is headquartered in San Francisco, California.

Official WebsiteUSAFY End: September

Fundamentals

Revenue (TTM)$1.35B
Gross Profit (TTM)$1.19B
EBITDA$354.67M
Operating Margin12.60%
Return on Equity8.76%
Return on Assets5.15%
Revenue/Share (TTM)$14.24
Book Value$27.59
Price-to-Book2.10
Price-to-Sales (TTM)4.15
EV/Revenue3.554
EV/EBITDA13.18
Quarterly Earnings Growth (YoY)-37.50%
Quarterly Revenue Growth (YoY)-3.30%
Shares Outstanding$59.42M
Float$58.76M
% Insiders1.87%
% Institutions106.61%

Historical Volatility

HV 10-Day
22.69%
HV 20-Day
19.51%
HV 30-Day
25.60%
HV 60-Day
36.02%
HV Rank
52.8%

Volatility is currently contracting

Analyst Ratings

Consensus ($79.00 target)
1
Strong Buy
2
Buy
1
Hold

Latest News

Dolby Laboratories Announces Conference Call and Webcast for Q4 Fiscal 2026 Financial Results

SAN FRANCISCO, Oct. 12, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment, will release financial results for the fourth quarter (Q4) and full year fiscal 2026 after the close of regular trading on Tuesday, November 17, 2026. Members of Dolby management will lead a conference call open to all interested parties to discuss Q4 fiscal year 2026 financial results for Dolby Laboratories at 2:00 p.m.

PRNewsWire10/12/2026Neutral
Dolby Laboratories: Weak Growth, But The Valuation Is Too Cheap

Dolby Laboratories is rated Buy due to its high margins, robust buyback program, and undervalued share price despite weak growth. DLB's 90% gross margin and operating leverage enable EPS growth even with modest revenue increases and stagnant licensing. Share repurchases—authorized up to $427 million—could alone drive EPS to levels supporting a 15x multiple and 20%+ upside.

Seeking Alpha10/5/2026Neutral
Dolby Expands Dolby OptiView Platform with New Capabilities at IBC 2026

New Sports Intelligence helps providers better understand and deepen fan engagement, as Dolby Vision comes to the platform alongside updates to Dolby OptiView Ads AMSTERDAM, Sept. 10, 2026 /PRNewswire/ -- Dolby Laboratories (NYSE: DLB), a leader in immersive entertainment experiences, today announced major updates to Dolby OptiView, its live sports platform, ahead of IBC 2026.

PRNewsWire9/10/2026Neutral
Dolby Laboratories Announces Leadership Transition

Kevin Yeaman to Retire from Dolby  Marc Whitten Named President, Chief Executive Officer and Director of Dolby SAN FRANCISCO, Aug. 27, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), today announced a new chapter in its leadership as Kevin Yeaman retires from Dolby after nearly two decades with the company and Marc Whitten is appointed President, Chief Executive Officer and a member of Dolby Laboratories' Board of Directors. After a thoughtful, long-term succession process Dolby Laboratories' Board appointed Marc to lead the company's next chapter.

PRNewsWire8/27/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on DLB and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More INDUSTRIALS Stocks

Data last updated: 10/17/2026